The Fast Money traders take a look at today's biggest market movers.» Read More
The morning after Amgen reported its first quarter earnings my inbox runneth over with analyst research reports on the biotech behemoth. The company beat the Street by eight cents a share. But the focus remains on the anemia drug franchise.
Chief executives from Europe discussed earnings, opportunities and challenges their companies face in 2008 with CNBC Europe Friday.
Nucor's CEO says these are the "best of times" for his cohort. Find out what Cramer thinks.
Pfizer held its shareholder meeting Thursday morning at the historic Memphis hotel where the ducks march through the lobby. I haven't seen the spectacle yet, but I'm told it's quite the scene. Watch my exclusive interview with Chairman and CEO Jeff Kindler.
Chief executives from Europe discussed earnings, opportunities and challenges their companies face in 2008 with CNBC Europe Thursday.
This is getting to be a habit for Ford Motor Chief Executive Alan Mulally. Once again, his company has posted better-than-expected quarterly earnings. This time, the company turned a $100 million profit when Wall Street was forecasting a loss of roughly $300 million.
Autopart recycling is a part of a broader secular trend that plays right into this company's business, Cramer says.
Schering-Plough beat the Street by a surprising 16 cents per share and the beaten-down shares are rallying. In an exclusive CNBC interview Wednesday morning, Chairman and CEO Fred Hassan explained how the company was able to blow away estimates...
Thursday will be a big day for European earnings, with heavyweights like Credit Suisse, Fiat and ABB set to hit the tape.
Two weeks after General Electric's earnings shortfall stunned Wall Street, Chief Executive Jeff Immelt said the market reaction was "tough," but deserved.
The CEO of this drilling company once honestly told Cramer that the time wasn't right to buy his stock. But now he thinks it's ready.
Media companies, like the New York Times Company and News Corp, are facing a new set of challenges, and CNBC's Julia Boorstin takes an in-depth look.
This halftime report is not brought to you by (pick your prescription drug). So, we're pretty much at the midway point of big pharma's earnings season and Goldman Sachs analyst James Kelly is sizing things up so far...
There is a fondness and attraction to Cadillac, Buick and Chevrolet that is helping GM make headway in China.
A bevy of chief executives appeared on CNBC Europe Tuesday to discuss topics ranging from quarter results to the environment to what the European Central Bank should be doing.
I usually cover pharma earnings from my desk at CNBC HQ in Englewood Cliffs, NJ. But because Merck made a rare offer to interview its Chairman and CEO Dick Clark exclusively this morning I'm out at Merck's idyllic HQ campus in central NJ.
Talk about coming of age. The Beijing Auto Show and China's auto market are making a statement this week. It's loud and clear: "We are world players!" In fact, it brings up the question about whether this show and the Chinese market are bigger than the Detroit Show and U.S. Market?
Jaguar and Land Rover's Chief Executive Geoff Polites, who is credited with steering the storied British luxury brands through the ongoing sale process to India's Tata Motors, has died.
The head of Societe Generale, the French bank that recently survived the world's biggest rogue trading scandal, is relinquishing his job as chief executive but will stay on as chairman.
Daniel Bouton will give up SocGen's chief executive role after 15 years but stay on as chairman. Finance Director Frederic Oudea will take the operational helm.